Nanomedicine in cancer stem cell therapy: from fringe to forefront

被引:20
作者
Tabassum, Nazish [1 ]
Verma, Vinod [1 ]
Kumar, Manoj [2 ]
Kumar, Ashok [3 ]
Singh, Birbal [4 ]
机构
[1] Univ Allahabad, Ctr Biotechnol, Nehru Sci Complex, Allahabad 211002, Uttar Pradesh, India
[2] ICMR, NIREH, Kamla Nehru Hosp Bldg, Bhopal, India
[3] MLK Post Grad Coll, Dept Zool, Balrampur, India
[4] Indian Vet Res Inst, Reg Stn, Palampur, Himachal Prades, India
关键词
Nanomedicine; Nanomaterials; Nanodevice; Cancer stem cells (CSCs); Drug delivery; TARGETED THERAPY; PHASE-I/II; IN-VITRO; REXIN-G; NANOPARTICLES; DRUG; COMBINATION; DELIVERY; DOXORUBICIN; PACLITAXEL;
D O I
10.1007/s00441-018-2928-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nanomedicine is the spin-off of modern medicine and nanotechnology and aims to prevent and treat diseases using nanoscale materials such as biocompatible nanoparticles and nanorobots. Targeted cellular and tissue-specific clinical applications with maximal therapeutic effects and insignificant side effects could be achieved by the pursuit of nanotechnology in medicine and healthcare regimen. The majority of conventional cancer therapies eliminate the cells of the tumor but not the cancer stem cells (CSCs). Conversely, the use of nanotechnology in CSC-based therapies is an emerging field of biomedical sciences. This article summarizes the recent trends and application of nanomedicine especially in CSC therapy along with its limitations.
引用
收藏
页码:427 / 438
页数:12
相关论文
共 50 条
  • [21] Nanomedicine for cancer targeted therapy with autophagy regulation
    He, Ketai
    Chen, Mingkun
    Liu, Jiao
    Du, Shufang
    Ren, Changyu
    Zhang, Jifa
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [22] The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies
    Singh, Vimal K.
    Saini, Abhishek
    Chandra, Ramesh
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2017, 4
  • [23] Engineered Mesenchymal Stem Cell/Nanomedicine Spheroid as an Active Drug Delivery Platform for Combinational Glioblastoma Therapy
    Suryaprakash, Smruthi
    Lao, Yeh-Hsing
    Cho, Hyeon-Yeol
    Li, Mingqiang
    Ji, Ha Yeun
    Shao, Dan
    Hu, Hanze
    Quek, Chai Hoon
    Huang, Dantong
    Mintz, Rachel L.
    Bago, Juli R.
    Hingtgen, Shawn D.
    Lee, Ki-Bum
    Leong, Kam W.
    NANO LETTERS, 2019, 19 (03) : 1701 - 1705
  • [24] Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
    Wu, Ping-Hsiu
    Opadele, Abayomi Emmanuel
    Onodera, Yasuhito
    Nam, Jin-Min
    CANCERS, 2019, 11 (11)
  • [25] Epigenetics in cancer therapy and nanomedicine
    Annalisa Roberti
    Adolfo F. Valdes
    Ramón Torrecillas
    Mario F. Fraga
    Agustin F. Fernandez
    Clinical Epigenetics, 2019, 11
  • [26] Epigenetics in cancer therapy and nanomedicine
    Roberti, Annalisa
    Valdes, Adolfo F.
    Torrecillas, Ramon
    Fraga, Mario F.
    Fernandez, Agustin F.
    CLINICAL EPIGENETICS, 2019, 11 (1)
  • [27] Cancer stem cell theory: therapeutic implications for nanomedicine
    Wang, Ke
    Wu, Xianguo
    Wang, Jianwei
    Huang, Jian
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 899 - 908
  • [28] Photoacoustic-based nanomedicine for cancer diagnosis and therapy
    Sim, Changbeom
    Kim, Haemin
    Moona, Hyungwon
    Lee, Hohyeon
    Chang, Jin Ho
    Kim, Hyuncheol
    JOURNAL OF CONTROLLED RELEASE, 2015, 203 : 118 - 125
  • [29] Stem cell-nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy
    Lai, Yen-Ho
    Su, Chia-Yu
    Cheng, Hung-Wei
    Chu, Chao-Yi
    Jeng, Long-Bin
    Chiang, Chih-Sheng
    Shyu, Woei-Cherng
    Chen, San-Yuan
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [30] Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy
    Boone, Christine E.
    Wang, Lu
    Gautam, Aayushma
    Newton, Isabel G.
    Steinmetz, Nicole F.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2022, 14 (01)